Welcome to Ypsomed: On August 4, 2025, we welcomed 28 apprentices in Switzerland, who have started their apprenticeships with us in various professions. We look forward to the fresh ideas and new energy they bring with them and wish them all a successful start to their careers 🍀🥳! #ypsomed #berufsbildung #YoungTalents
Ypsomed AG
Herstellung medizinischer Geräte
Making selfcare simpler and easier.
Info
Ypsomed is the leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist. The company celebrated its 40th anniversary in 2024. As a leader in innovation and technology, it is a preferred partner of pharmaceutical and biotech companies for pens, autoinjectors and pump systems for administering liquid medications. Ypsomed presents and markets its product portfolios under the umbrella brand mylife Diabetescare directly to patients, pharmacies and hospitals as well as under Ypsomed Delivery Systems in business-to-business operations with pharmaceutical companies. Ypsomed is headquartered in Burgdorf, Switzerland. The company has a global network of production facilities, subsidiaries and distribution partners. Ypsomed has over 2 800 employees worldwide.
- Website
-
https://xmrrwallet.com/cmx.pwww.ypsomed.com/en/company/ypsostories.html
Externer Link zu Ypsomed AG
- Branche
- Herstellung medizinischer Geräte
- Größe
- 1.001–5.000 Beschäftigte
- Hauptsitz
- Burgdorf
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 2003
- Spezialgebiete
- diabetes care, manufacturer, injection systems, selfcare solutions, blood glucose monitoring systems, infusion systems, insulin pumps und digital health
Orte
-
Primär
Brunnmattstrasse 6
Burgdorf, 3401, CH
-
Weissensteinstrasse 26
Solothurn, 4503, CH
Beschäftigte von Ypsomed AG
-
Simon Michel
CEO and Member of the Board at Ypsomed Group and Member of the Swiss National Council
-
Kristen Garland, MAN, RD, CDE
-
Carlos Reboll Romero
General Manager | Sustainable Growth and Expansion | New Market Access | Product Commercialisation | Investment in People | Experience in Multiple…
-
Frederic Richard
Ypsomed Diabetes Care Business Development Director
Updates
-
How does Ypsomed’s platform approach support a seamless path from clinical supply to commercial scale-up 🚀? ☑️ Agile setup ☑️ Flexible tooling ☑️ Configurable devices ☑️ Variant scale-up We enable pharmaceutical partners to move from trials to market with confidence. Learn more about our flexible setup in a recent article by Philipp Richard, published in ONdrugDelivery 👉 https://xmrrwallet.com/cmx.pbrnw.ch/21wUJdm #ypsomed #OnDrugDelivery #SelfInjection #manufacturing #medtech
-
-
Ypsomed Holding AG announced today that it has successfully completed the sale of its Ypsomed Diabetes Care business to TecMed AG 👍. Read more 👉 https://xmrrwallet.com/cmx.plnkd.in/d9D2eSQP #ypsomed #tecmed
-
What does it take to design a worry-free wearable injector 💡? Our latest blog from Christian Schmid takes us behind the scenes on the human factors journey of YpsoDose, Ypsomed’s large-volume, pre-filled and ready-to-use patch injector. From early UI concepts to patient testing and refinement, every step focused on one thing: making self-injection simpler, safer, and more intuitive✔️. 💡 Patient centricity from day one 💡 Real user feedback, real impact 💡 A design shaped by insight and evidence This is how ease of use gets built in. Read the full blog on the design history of YpsoDose 👉 https://xmrrwallet.com/cmx.pbrnw.ch/21wUyUF #ypsomed #wearables #YpsoDose #medtech #PatchInjector
-
-
We’re live at the PDA India Chapter Meeting in Hyderabad ⚡! Great conversations are already underway, and YpsoFlow is in the spotlight 💡. Come by table 5 to learn more, ask questions, and connect with the team 🤝. Let’s talk self-injection and GLP-1 access 🌐! PDA - Parenteral Drug Association #PDA #ypsomed #YpsoFlow
-
-
Just published 🎉: Self-Injection Device Manufacturing in a Dynamic World by Philipp Richard of Ypsomed is now live in the July edition of ONdrugDelivery. The in-depth piece traces the industrial evolution of self-injection devices, from early reusable pens mostly designed for insulin, to today’s wide range of platform products, and offers a detailed look at how flexible manufacturing is key to meeting today’s evolving and ambitious demands. A look at where the field has been—and where it is going 👀. Read the full article below 👇. ONdrugDelivery #ypsomed #OnDrugDelivery #SelfInjection #manufacturing #medtech
-
In the City of Pearls, we are showcasing value that lasts 🤩. Join us at the PDA India Chapter Meeting in Hyderabad (30 Jul–1 Aug) to discuss GLP-1, and how we are rethinking reusables with our 750 μL versions of YpsoPen and ServoPen, and driving access with YpsoFlow, our new spring-driven, pre-filled pen. Let us talk options. See you at table no. 5 💬! #pda #hyderabad #DrugDelivery #ypsomed #India
-
We were honored with the Gold Award in the Drug Delivery Innovation category at the CPHI China Pharma Awards 2025 🏆! Our pre-filled, ready-to-use YpsoDose patch injector platform impressed with its innovative technology for automated drug delivery of high-volume drugs 💉. The jury particularly praised the combination of technological excellence, patient comfort, and manufacturing quality 🤝. #ypsomed #DrugDelivery #cphichina #pharmatech
-
As part of the "Erlebnistage Beruf" event 🚀, we welcomed numerous interested school pupils 👩🎓👨🎓 from the canton of Solothurn to our offices 🏢. Exciting insights into the world of medical technology 💉 gave the young people an opportunity to experience what it means to work at Ypsomed on solutions for the healthcare of tomorrow 💡🤝🌍.
-
-
Last week was a time for celebration 🎉 – and rightly so: 17 of our apprentices in Switzerland successfully completed their apprenticeship at Ypsomed 🎓👏. Congratulations to all of you 🎊 You can be really proud of yourselves 🌟💪! #ypsomed #apprenticeship
-